Impax Asset Management Group
EXAS

Impax Asset Management Group’s Exact Sciences EXAS Stock Holding History

Impax Asset Management Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,945
Closed -$292K – 327
2023
Q4 		$292K Sell
3,945
-413
-9% -$27.1K ﹤0.01% 355
2023
Q3 		$297K Buy
4,358
+772
+22% +$65.5K ﹤0.01% 377
2023
Q2 		$337K Sell
3,586
-49
-1% -$3.82K ﹤0.01% 371
2023
Q1 		$246K Buy
+3,635
New +$234K ﹤0.01% 386
2022
Q3 		– Sell
-6,171
Closed -$243K – 402
2022
Q2 		$243K Sell
6,171
-487
-7% -$26K ﹤0.01% 370
2022
Q1 		$466K Buy
6,658
+302
+5% +$22.1K ﹤0.01% 349
2021
Q4 		$494K Buy
+6,356
New +$561K ﹤0.01% 343

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Impax Asset Management Group's EXAS Position: Q1 2024 in Review

Impax Asset Management Group sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,945 shares — an estimated $292K sold.

Impax Asset Management Group first reported a position in EXAS in Q4 2021 and held it in 7 quarters. The position peaked at $494K in Q4 2021. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Impax Asset Management Group reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Impax Asset Management Group sold 3,945 Exact Sciences shares in Q1 2024, an estimated $292K.
  • Impax Asset Management Group first reported a position in Exact Sciences in Q4 2021 and held it in 7 quarters.
  • Impax Asset Management Group's Exact Sciences position peaked at $494K in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Impax Asset Management Group's 13F filing for Q1 2024, filed 30 Apr 2024.